skip to main content

Title: HIV vaccine enters human efficacy trials

The HIV mosaic vaccine was originally designed at Los Alamos National Laboratory using a machine learning algorithm designed by Bette Korber and her team. It's the first computationally designed HIV vmore »accine. Through a decade of testing, it has shown promise and is now in human efficacy trials. The study will evaluate whether the investigational vaccine regimen is safe and able to reduce the incidence of HIV infection among 2,600 sexually active women in sub-Saharan Africa. The new study, HVTN 705/HPX2008, is known as “Imbokodo,” the Zulu word for “rock,” from a South African saying that refers to the strength of women and their importance in the community.« less
Title: HIV vaccine enters human efficacy trials
Authors:
Publication Date: 2018-10-05
OSTI Identifier: 1487129
Resource Type: Multimedia
Specific Type: video
Research Org: LANL (Los Alamos National Laboratory (LANL), Los Alamos, NM (United States))
Sponsoring Org: USDOE National Nuclear Security Administration (NNSA)
Subject: 59 BASIC BIOLOGICAL SCIENCES ; HIV MOSAIC VACCINE ; IMBOKODO ; TRANSMISSIBLE DISEASE ; MACHINE LEARNING ; HIV GENOME DATABASE ; COMPUTER-GENERATED VACCINE SEQUENCE
Country of Publication: United States
Language: English
Run Time:
System Entry Date: 2018-12-19